Bone mineral density in children with sickle cell anemia

Pediatric Blood and Cancer

Volumn 47, Issue 7, 2006, Pages 901-906

  Lal, Ashutosh ^a   Fung, Ellen B ^a   Pakbaz, Zahra ^a   Hackney Stephens, Ekua ^a   Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Bone markers; Bone mineral density; Calcium; Sickle cell anemia; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; FERRITIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERALIZATION; BONE TURNOVER; CALCIUM INTAKE; CALCULATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE TRANSFUSION; ETHNIC DIFFERENCE; EVALUATION; FEMALE; FEMUR FRACTURE; FERRITIN BLOOD LEVEL; GROWTH RETARDATION; HOSPITAL ADMISSION; HUMAN; LUMBAR SPINE; MALE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ANEMIA, SICKLE CELL; BONE DENSITY; CALCIUM, DIETARY; CHILD; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; OSTEOCALCIN; PEPTIDES; VITAMIN D;

EID: 33750466901     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20681     Document Type: Article

References (30)

1. Vichinsky E. New therapies in sickle cell disease. Lancet 2002; 360:629-631.
2. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-4027.
3. Desai MM, Zhang PHennessy CH. Surveillance for morbidity and mortality among older adults-United States, 1995-1996. MMWRCDC Surveill Summ 1999;48:7-25.
4. Trombetti A, Herrmann F, Hoffmeyer P, et al. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002;13:731-737.
5. Soyka LA, Fairfield WP, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2000;85:3951-3963.
6. Barden EM, Kawchak DA, Ohene-Frempong K, et al. Body composition in children with sickle cell disease. Am J Clin Nutr 2002;76:218-225.
7. Buison AM, Kawchak DA, Schall J, et al. Low vitamin D status in children with sickle cell disease. J Pediatr 2004;145:622-627.
8. Brinker MR, Thomas KA, Meyers SJ, et al. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop 1998;27:43-49.
9. Soliman AT, Bererhi H, Darwish A, et al. Decreased bone mineral density in prepubertal children with sickle cell disease: Correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998;44:194-198.
10. VanderJagt DJ, Bonnett C, Okolo SN, et al. Assessment of the bone status of nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone metabolism. Calcif Tissue Int 2002;71:133-140.
11. Seibel MJ. Biochemical markers of bone remodeling. Endocrinol Metab Clin North Am 2003;32:83-113.
12. Gordon CM, Bachrach LK, Carpenter TO, et al. Bone health in children and adolescents: A symposium at the Annual Meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003. Curr Probl Pediatr Adolesc Health Care 2004;34:226-242.
13. Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy asian, hispanic, black, and Caucasian youth: A longitudinal study. J Clin Endocrinol Metab 1999;84:4702-4712.
14. Katzman DK, Bachrach LK, Carter DR, et al. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991;73:1332-1339.
15. Khan AA, Bachrach L, Brown JP, et al. Standards and guidelines for performing central dual-energy X-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom 2004;7:51-64.
16. Nelson DA, Rizvi S, Bhattacharyya T, et al. Trabecular and integral bone density in adults with sickle cell disease. J Clin Densitom 2003;6:125-129.
17. Sadat-Ali M, Ammar A, Corea JR, et al. The spine in sickle cell disease. Int Orthop 1994;18:154-156.
18. Benigno V, Bertelloni S, Baroncelli GI, et al. Effects of thalassemia major on bone mineral density in late adolescence. J Pediatr Endocrinol Metab 2003;16:337-342.
19. Jensen CE, Tuck SM, Agnew JE, et al. High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 1998;11:975-977.
20. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004;127:127-139.
21. Voskaridou E, Terpos E, Spina G, et al. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol 2003;123:730-737.
22. Vichinsky E, Butensky E, Fung E, et al. Comparison of organ dysfunction in transfused patients with scd or beta-thalassemia. Am J Hematol 2005;80:70-74.
23. Wang MC, Aguirre M, Bhudhikanok GS, et al. Bone mass and hip axis length in healthy asian, black, hispanic, and white american youths. J Bone Miner Res 1997;12:1922-1935.
24. Ervin RB, Wang CY, Wright JD, et al. Dietary intake of selected minerals for the United States population: 1999-2000. Adv Data 2004;341:1-5.
25. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-322.
26. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Larsen PR, Kronenberg HM, Melmed S, et al. Williams textbook of endocrinology. Philadelphia: W.B. Saunders; 2003, pp 1318-1320.
27. Seydewitz HH, Henschen M, Kuhnel W, et al. Pediatric reference ranges for osteocalcin measured by the immulite analyzer. Clin Chem Lab Med 2001;39:980-982.
28. van der Sluis IM, Hop WC, van Leeuwen JP, et al. A cross-sectional study on biochemical parameters of bone turnover and vitamin D metabolites in healthy dutch children and young adults. Horm Res 2002;57:170-179.
29. Fares JE, Choucair M, Nabulsi M, et al. Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodedeling. Bone 2003;33:242-247.
30. Tobiume H, Kanzaki S, Hida S, et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: A potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997;82:2056-2061.